Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome

The New England Journal of Medicine
Kenneth P SteinbergNational Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network

Abstract

Persistent acute respiratory distress syndrome (ARDS) is characterized by excessive fibroproliferation, ongoing inflammation, prolonged mechanical ventilation, and a substantial risk of death. Because previous reports suggested that corticosteroids may improve survival, we performed a multicenter, randomized controlled trial of corticosteroids in patients with persistent ARDS. We randomly assigned 180 patients with ARDS of at least seven days' duration to receive either methylprednisolone or placebo in a double-blind fashion. The primary end point was mortality at 60 days. Secondary end points included the number of ventilator-free days and organ-failure-free days, biochemical markers of inflammation and fibroproliferation, and infectious complications. At 60 days, the hospital mortality rate was 28.6 percent in the placebo group (95 percent confidence interval, 20.3 to 38.6 percent) and 29.2 percent in the methylprednisolone group (95 percent confidence interval, 20.8 to 39.4 percent; P=1.0); at 180 days, the rates were 31.9 percent (95 percent confidence interval, 23.2 to 42.0 percent) and 31.5 percent (95 percent confidence interval, 22.8 to 41.7 percent; P=1.0), respectively. Methylprednisolone was associated with significa...Continue Reading

References

Aug 1, 1992·Critical Care Medicine·S BraudeT W Evans
Dec 17, 1987·The New England Journal of Medicine·G R BernardC A Metz
May 1, 1985·Archives of Surgery·J A WeigeltW H Snyder
Dec 1, 1995·American Journal of Surgery·W L BifflJ M Burch
Mar 1, 1994·American Journal of Respiratory and Critical Care Medicine·G R BernardR Spragg
Jul 1, 1994·American Journal of Respiratory and Critical Care Medicine·K P SteinbergL D Hudson
Jan 1, 1995·Ryōikibetsu shōkōgun shirīzu·T Fukazawa
Sep 1, 1996·American Journal of Respiratory and Critical Care Medicine·R B GoodmanT R Martin
Jul 21, 1998·JAMA : the Journal of the American Medical Association·G U MeduriE A Tolley
Sep 8, 1998·Respiration; International Review of Thoracic Diseases·J B KeelR Speich
May 4, 2000·The New England Journal of Medicine·UNKNOWN Acute Respiratory Distress Syndrome NetworkArthur Wheeler
May 4, 2000·The New England Journal of Medicine·L B Ware, M A Matthay
May 18, 2000·The New England Journal of Medicine·J P KressJ B Hall
Mar 10, 2001·The New England Journal of Medicine·G R BernardUNKNOWN Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group
Dec 6, 2001·American Journal of Respiratory and Critical Care Medicine·W Y ParkT R Martin
Jan 17, 2002·The New England Journal of Medicine·G van den BergheR Bouillon
Aug 21, 2002·JAMA : the Journal of the American Medical Association·Djillali AnnaneEric Bellissant
Nov 12, 2002·American Journal of Respiratory and Critical Care Medicine·Didier KehHerwig Gerlach
Dec 11, 2002·JAMA : the Journal of the American Medical Association·Bernard De JongheUNKNOWN Groupe de Réflexion et d'Etude des Neuromyopathies en Réanimation
Feb 21, 2003·The New England Journal of Medicine·Margaret S HerridgeUNKNOWN Canadian Critical Care Trials Group
Mar 18, 2003·Annals of Internal Medicine·Harold R CollardMichael A Matthay
Aug 4, 2004·BMJ : British Medical Journal·Djillali AnnaneYizhak Kupfer

❮ Previous
Next ❯

Citations

Feb 5, 2008·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Malcolm Daniel
Jun 24, 2006·Intensive Care Medicine·Marc Moss
Jul 20, 2007·Intensive Care Medicine·Robert D StevensDale M Needham
Oct 24, 2007·Intensive Care Medicine·Damon C Scales, Andreas Laupacis
Nov 15, 2007·Intensive Care Medicine·G Umberto MeduriDjillali Annane
Dec 7, 2007·Intensive Care Medicine·R Phillip DellingerJean-Louis Vincent
Oct 24, 2008·Intensive Care Medicine·Catherine L HoughLeonard D Hudson
Nov 29, 2011·Intensive Care Medicine·Djillali AnnaneUNKNOWN REVA/SRLF networks
Mar 28, 2012·General Thoracic and Cardiovascular Surgery·Tomohito SadahiroKoichiro Shinozaki
Sep 21, 2007·Current Infectious Disease Reports·Sachin Yende, Derek C Angus
Aug 9, 2008·Current Infectious Disease Reports·Didier KehOlaf Ahlers
Feb 15, 2007·Current Treatment Options in Neurology·Shawn J Bird
Jul 29, 2011·Neurocritical Care·P D Le RouxJ I Suarez
Jul 28, 2011·Neurocritical Care·J I SuarezO O Zaidat
Apr 23, 2013·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·François LamontagneMaureen O Meade
Aug 13, 2008·Nature Clinical Practice. Endocrinology & Metabolism·Dieter MesottenGreet Van den Berghe
Jul 7, 2009·Nature Reviews. Neurology·Wolfgang ZinkStefan Schwab
Sep 15, 2006·The New England Journal of Medicine·Dan Schuller, Daniel P Schuster
Jul 21, 2006·The New England Journal of Medicine·Paul MarikDjillali Annane
Apr 21, 2006·The New England Journal of Medicine·Peter M Suter
Jan 11, 2008·The New England Journal of Medicine·Charles L SprungUNKNOWN CORTICUS Study Group
Apr 8, 2011·The New England Journal of Medicine·Margaret S HerridgeUNKNOWN Canadian Critical Care Trials Group
Oct 20, 2006·The New England Journal of Medicine·James A Russell
Jan 16, 2010·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Elizabeth R Johnson, Michael A Matthay
May 29, 2009·British Journal of Anaesthesia·N R Webster, H F Galley
Jun 21, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Pablo A VialUNKNOWN Hantavirus Study Group in Chile
Aug 19, 2006·Critical Care Medicine·Mark R Hemmila, Lena M Napolitano
Apr 7, 2007·Critical Care Medicine·Yaseen ArabiZiad A Memish
Dec 26, 2007·Critical Care Medicine·R Phillip DellingerUNKNOWN World Federation of Societies of Intensive and Critical Care Medicine
Sep 1, 2006·Current Opinion in Critical Care·Jeremy M Kahn
Sep 1, 2006·Current Opinion in Critical Care·Shannon S Carson
Jun 5, 2007·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Simon EricksonUNKNOWN Australian and New Zealand Intensive Care Society
Feb 7, 2013·Current Opinion in Anaesthesiology·Baruch M BatzofinStephane F Ledot
Jan 10, 2009·International Anesthesiology Clinics·Georges A CehovicBrenda G Fahy
Mar 20, 2008·Current Opinion in Rheumatology·Allyson K McDonoughKenneth G Saag
Apr 2, 2008·Critical Care Medicine·Gustavo A Ospina-TascónJean-Louis Vincent
Sep 4, 2008·Critical Care Medicine·Jason PhuaNiall D Ferguson
Jun 4, 2008·Critical Care Medicine·R Phillip Dellinger
Aug 30, 2008·Critical Care Medicine·Carl Roosens, Jan Poelaert

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials NetworkAndrea L Harabin
© 2022 Meta ULC. All rights reserved